| 000 | 03534cam a2200553Ii 4500 | ||
|---|---|---|---|
| 001 | on1236251398 | ||
| 003 | OCoLC | ||
| 005 | 20220525145507.0 | ||
| 006 | m d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 210205s2021 si ob 000 0 eng d | ||
| 020 |
_a9789813363007 _q(electronic bk.) |
||
| 020 |
_a9813363002 _q(electronic bk.) |
||
| 020 | _z9813362995 | ||
| 020 | _z9789813362994 | ||
| 024 | 7 |
_a10.1007/978-981-33-6300-7 _2doi |
|
| 035 | _a2745512 | ||
| 035 |
_a(OCoLC)1236251398 _z(OCoLC)1237399090 _z(OCoLC)1240637150 |
||
| 040 |
_aYDX _beng _erda _cYDX _dYDXIT _dGW5XE _dOCLCO _dEBLCP _dN$T |
||
| 049 | _aMAIN | ||
| 050 | 4 |
_aRA644.C67 _bT22 2021 |
|
| 072 | 7 |
_aPHVN _2bicssc |
|
| 072 | 7 |
_aSCI009000 _2bisacsh |
|
| 072 | 7 |
_aPHVN _2thema |
|
| 072 | 7 |
_aPHVD _2thema |
|
| 082 | 0 | 4 |
_a614.5/92414 _223 |
| 100 | 1 |
_aT., Devasena, _eauthor. |
|
| 245 | 1 | 0 |
_aNanotechnology-COVID-19 interface / _cDevasena T. |
| 264 | 1 |
_aSingapore : _bSpringer, _c[2021] |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 | _aSpringerBriefs in applied sciences and technology. Nanotheranostics. | |
| 504 | _aIncludes bibliographical references. | ||
| 505 | 0 | _a1. introduction to COVID-19 -- 2. STRUCTURE OF SARS COV2 -- 3. TROPISM OF SARS COV2 -- 4. NANOTECHNOLOGY-COVID 19 INTERFACE -- 5. NANOPARTICLES IN DIAGNOSIS OF COVID-19. | |
| 520 | _aThis book highlights the role of nanotechnology concepts in the management of COVID-19 pandemic. The book covers different aspects of the causative agent SARS CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) and the COVID-19 pandemic with a special emphasis on nanotechnology. It discusses the origin and history of SARS CoV2 and the outbreak of COVID-19 and highlights the geographical mutations in the SARS CoV2 virus genome, providing information about the structural features, antigenicity and the life cycle of SARS CoV2. The book provides an insight into nanotechnology-virology interface and explains how nanomaterials link the gap between the vital phases of SARS CoV2 life cycle and the four modalities of COVID-19 management viz sensing/diagnosis, therapy, prevention and self-protection. Further, the existing and promising diagnostic tools for detection of COVID-19 are discussed with an emphasis on nano PCR, nanoimmunosensors, biobarcode assay and point of care approach and also describe the nanoparticles involved in the CT imaging of lungs and SFHI (Spatial Frequency Hetrodyne Imaging) for diagnosis of SARS COV2 infection. The book concludes with details about translational medicine and explains the types of SARS CoV2 vaccines, stages of COVID-19 vaccine development and possible nanovaccines for COVID-19, followed by the description on biopharmaceutical companies involved in the production of SARS CoV2 vaccines. | ||
| 588 | _aDescription based on online resource; title from digital title page (viewed on March 11, 2021). | ||
| 590 | _aAdded to collection customer.56279.3 | ||
| 650 | 0 | _aCOVID-19 (Disease) | |
| 650 | 0 | _aCOVID-19 Pandemic, 2020- | |
| 650 | 0 | _aNanomedicine. | |
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _z9813362995 _z9789813362994 _w(OCoLC)1225190481 |
| 830 | 0 |
_aSpringerBriefs in applied sciences and technology. _pNanotheranostics. |
|
| 850 | _aSHTL | ||
| 856 | 4 | 0 |
_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2745512 |
| 942 |
_2nlm _cEBK |
||
| 999 |
_c36079 _d36079 |
||